Polycyclic Aromatic Hydrocarbons in Fish Oil: The Contamination Risk Omega-3 Brands Rarely Test For

The U.S. omega-3 supplement market generates well over $1.5 billion in annual retail sales, with fish oil accounting for the vast majority of that volume. Most brands selling into that market have an oxidation testing protocol: peroxide value (PV), anisidine value (AV), and the composite TOTOX score have become table stakes for any serious quality program. What’s far less common — and far less discussed — is testing for polycyclic aromatic hydrocarbon contamination.

That’s a gap worth taking seriously. PAHs are a family of more than 100 organic compounds generated whenever organic material undergoes incomplete combustion or thermal decomposition. They exist in engine exhaust, industrial smoke, and petroleum products. They also exist in marine environments that receive runoff from shipping traffic, industrial coastlines, and petroleum spills — the same environments where the fish that become your omega-3 capsules spend their lives.

Why Fish Oil Is Uniquely Vulnerable to PAH Accumulation

Fish bioaccumulate PAHs through a straightforward mechanism: these compounds are lipophilic, meaning they partition preferentially into fatty tissue rather than water or muscle. Pelagic species — anchovies, sardines, and mackerel are the workhorses of supplement-grade fish oil production — filter enormous volumes of water as they feed. In pristine open-ocean environments, PAH exposure is minimal. In waters near industrial coastlines or with elevated petroleum contamination, the bioaccumulation math shifts considerably.

The 2010 Deepwater Horizon disaster released an estimated 4.9 million barrels of crude oil into the Gulf of Mexico. Post-spill research documented elevated PAH concentrations in Gulf fish for years afterward, with some species showing benzo[a]pyrene levels above EU regulatory limits for food oils. The Gulf isn’t a primary source of supplement-grade fish oil, but the example illustrates something important: marine PAH burdens are not static, they shift with environmental events, and the effects persist in the food chain long after the headlines fade. The Baltic Sea, the South China Sea near refining infrastructure, and various coastal zones around Southeast Asia all carry above-baseline PAH loads that don’t disappear at the processing dock.

Concentration risk doesn’t stop at sourcing, either. Crude fish oil undergoes rendering, pressing, refining, deodorization, and — in higher-quality operations — molecular distillation. Done correctly, distillation removes a meaningful fraction of PAH compounds, since many PAHs have higher boiling points than the omega-3 fatty acids being concentrated. Done poorly, or skipped to reduce cost, it provides no protective benefit. And without an independent analytical test, a brand importing refined fish oil from a contract manufacturer has no way to distinguish between those two scenarios from a COA alone.

The Regulatory Picture: Where EU Standards End and the US Gap Begins

The European Union regulates PAHs in food oils through Commission Regulation (EC) No. 1881/2006, as subsequently amended. For oils and fats intended for direct human consumption — a category that explicitly covers fish oil — the current limits are:

• Benzo[a]pyrene: maximum 2 µg/kg
• PAH4 (the sum of benzo[a]pyrene, chrysene, benzo[b]fluoranthene, and benzo[a]anthracene): maximum 10 µg/kg

These aren’t aspirational targets. EU member states test products at point of entry and through market surveillance, and non-compliant findings get logged in the RASFF (Rapid Alert System for Food and Feed) database — a publicly searchable record that attracts exactly the kind of attention brand managers work hard to avoid.

The U.S. regulatory picture is considerably less defined. FDA has not established specific numerical PAH limits for dietary supplements or fish oil. The agency’s general adulteration provisions under 21 CFR Part 111 — the GMP rule for dietary supplements — require manufacturers to ensure their products are free from contamination, but without a specific numerical threshold, enforcement is reactive rather than structural. A brand can receive a warning letter after a problem surfaces; there’s no pre-market standard to test against.

California’s Proposition 65 changes that calculus for any brand selling into the state. Benzo[a]pyrene is listed as a Prop 65 carcinogen, and the No Significant Risk Level — the daily intake below which warning requirements don’t apply — is 0.06 µg/day. That’s a very small number. Depending on the serving size and the benzo[a]pyrene concentration in the finished product, fish oil supplements could trigger Prop 65 labeling obligations even at contamination levels that the EU would consider compliant. The math isn’t hypothetical; it’s the kind of calculation a regulatory attorney is going to run when your product draws attention.

Third-party voluntary certification programs have stepped into this gap to varying degrees. The International Fish Oil Standards (IFOS) program includes PAH testing in its five-star certification criteria. The Global Organization for EPA and DHA Omega-3s (GOED) publishes a voluntary monograph with quality specifications, though individual member compliance varies. These programs are useful signals of supplier intent — but they’re not a substitute for independent batch-level verification.

How an ISO 17025 Lab Actually Tests for PAHs in Fish Oil

PAH analysis in a lipid matrix is not simple analytics. The challenge begins with sample preparation: PAHs need to be extracted from the fish oil matrix before detection, and the fat itself will foul chromatographic columns and detectors if not adequately removed. Standard approaches include liquid-liquid extraction with appropriate organic solvents, followed by solid-phase extraction (SPE) cleanup to reduce matrix interference. The specific sorbent and elution chemistry matter — the wrong cleanup method produces poor recovery data, and poor recovery means low concentrations look even lower than they are.

Detection is performed by one of two primary methods:

GC-MS (Gas Chromatography–Mass Spectrometry) is the regulatory gold standard for PAH analysis. It separates individual PAH compounds by their volatility and molecular mass, allowing positive identification and quantification of specific analytes — benzo[a]pyrene, chrysene, benzo[b]fluoranthene, benzo[a]anthracene — down to concentrations in the low parts-per-billion range. GC-MS is the preferred method when EU PAH4 compliance data is needed, since regulators want individual analyte results, not a total PAH figure.

HPLC with Fluorescence Detection (HPLC-FLD) offers comparable sensitivity and is often preferred for high-throughput laboratories. PAHs are naturally fluorescent, which gives fluorescence detection strong selectivity without the instrument complexity of mass spectrometry. For quality monitoring programs that don’t require EU regulatory-format reporting, HPLC-FLD is a practical and cost-effective option.

At our lab, PAH panels for fish oil are run against certified reference standards, with documented method detection limits, calibration linearity data, and matrix spike recovery results. That’s what ISO 17025 accreditation actually requires — not just running the analysis, but demonstrating through documented validation that the method works reliably for the specific matrix being tested. Fish oil is a demanding matrix; a method validated for water or soil isn’t automatically appropriate here.

One point worth flagging: there’s a meaningful difference between an EPA Method 8270 panel (the standard 16-PAH suite used in environmental testing) and an EU PAH4 panel designed for food compliance. Both measure PAHs, but they’re targeting different analyte lists and applying different method criteria. Brands that ask for “PAH screening” without specifying which regulatory framework they’re targeting often receive data that doesn’t fully serve their compliance needs. Get alignment with your lab on that question before samples ship.

What to Ask Your Supplier — And What to Look for in Their Documentation

If fish oil is an ingredient in your product — as the primary oil, a carrier oil in softgels, or a component in a blend — these questions should be part of your supplier qualification process, not an afterthought.

Source and fishery transparency: Where was the fish caught, and in which body of water? Not all marine environments carry equivalent PAH risk. Suppliers sourcing from certified fisheries in the South Pacific, Norwegian Sea, or Peruvian Pacific generally present lower PAH exposure than those sourcing from more industrialized coastal regions. Fishery certifications like MSC don’t directly address PAH levels, but they indicate traceability — which means you can actually ask and get an answer.

Processing documentation: Was the crude oil molecularly distilled? Can the supplier provide batch-specific COAs that include PAH data alongside the standard oxidation markers? A COA showing only peroxide value, AV, and TOTOX isn’t telling you the complete quality story — it’s showing you the freshness data and leaving out the contamination data entirely.

Quantitative results, not pass/fail notations: Benzo[a]pyrene at 0.3 µg/kg and benzo[a]pyrene at 1.8 µg/kg are both technically below the EU’s 2 µg/kg limit, but they represent meaningfully different quality levels — and they create very different headroom for Prop 65 exposure calculations at the finished-product level. Ask for actual numbers.

Independent verification at receiving: Supplier COAs are produced by the supplier’s quality system, under the supplier’s procedures. Periodic third-party verification — even once per year, even on a subset of batches — provides the independent confirmation that supplier documentation alone cannot. That’s particularly important for a contaminant class where the regulatory gap creates limited external accountability pressure on US-market suppliers.

The Practical Takeaway for Omega-3 Brands

Don’t drop oxidation testing — it remains a critical freshness indicator and is genuinely informative about shelf stability. But freshness and cleanliness are different qualities, and right now, most US omega-3 brands are measuring only one of them.

The practical starting point: request PAH4 data on current batches from your fish oil supplier. If they can’t provide it, or provide only a pass/fail notation without underlying numbers, that’s actionable information. If you’re launching a new product or onboarding a new supplier, add a PAH panel to your incoming raw material qualification protocol. The cost of the analysis is modest relative to the cost of a Prop 65 notice from a private enforcer, or the reputational impact of showing up in a consumer advocacy lab report.

The EU has decided these limits matter enough to regulate numerically. U.S. federal standards will likely follow — they usually do. And California’s Prop 65 NSRL of 0.06 µg/day means that waiting for federal action isn’t a neutral choice for brands with California distribution. The brands that build PAH testing into their quality program now will be ahead of that curve, not scrambling to catch up.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Raw Material COA Verification: What Omega-3 and Lipid Ingredient Buyers Should Demand — A deep look at supplier qualification and COA integrity for fatty acid raw materials.
• FDA Dietary Supplement Compliance Strategy: What Brands Need to Know Before Going to Market — Navigating 21 CFR Part 111, label claims, and the regulatory expectations that apply before your product ships.